contact us

Use the form on the right to contact us.

You can edit the text in this area, and change where the contact form on the right submits to, by entering edit mode using the modes on the bottom right.

         

123 Street Avenue, City Town, 99999

(123) 555-6789

email@address.com

 

You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.

Publications

Filtering by Tag: Yao Pan

Disparity in reimbursement for tuberculosis care among different health insurance schemes: evidence from three counties in central China

Future Health Systems

Pan Y, Chen S, Chen M, Zhang P, Long Q, Xiang L, and Lucas H (2016) Disparity in reimbursement for tuberculosis care among different health insurance schemes: evidence from three counties in central China, Infect Dis Poverty. 2016; 5: 7. doi: 10.1186/s40249-016-0102-4

Health inequity is an important issue all around the world. The Chinese basic medical security system comprises three major insurance schemes, namely the Urban Employee Basic Medical Insurance (UEBMI), the Urban Resident Basic Medical Insurance (URBMI), and the New Cooperative Medical Scheme (NCMS). Little research has been conducted to look into the disparity in payments among the health insurance schemes in China. In this study, the authors aimed to evaluate the disparity in reimbursements for tuberculosis (TB) care among the abovementioned health insurance schemes.

Read More

Are free anti-tuberculosis drugs enough? An empirical study from three cities in China

Future Health Systems

Chen S, Zhang H, Pan Y, Long Q, Xiang L, Yao L and Lucas H (2015) Are free anti-tuberculosis drugs enough? An empirical study from three cities in China, Infectious Diseases of Poverty, 4:47, doi:10.1186/s40249-015-0080-y

Tuberculosis (TB) patients in China still face a number of barriers in seeking diagnosis and treatment. There is evidence that the economic burden on TB patients and their households discourages treatment compliance.  Data were collected using a questionnaire survey, key informant interviews and focus group discussions with TB patients to gain an understanding of the economic burden of TB and implications of this burden for treatment compliance.

Read More